Schedule 13G ownership disclosure
H-Cyte Inc
Security class unavailable · CUSIP: 404124109
Event date: 2020-09-24
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 11.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193805-22-000342
- Form type
- SC 13G
- Filer
- Innoveren Scientific, Inc.
- CIK
- CIK 1591165
- Filed
- Feb 16, 2022
- Reporting period
- Sep 24, 2020
- Description
- Schedule 13G beneficial ownership